Where Will VBI Vaccines Inc (VBIV) Stock Go Next After It Has Fallen 9.68% in a Week?

Overall market sentiment has been down on VBI Vaccines Inc (VBIV) stock lately. VBIV receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

VBI Vaccines Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on VBIV!

See Full VBIV Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With VBIV Stock Today?

VBI Vaccines Inc (VBIV) stock is up 1.82% while the S&P 500 is down -1.11% as of 10:14 AM on Friday, Apr 22. VBIV is higher by $0.02 from the previous closing price of $1.37 on volume of 221,623 shares. Over the past year the S&P 500 is higher by 4.11% while VBIV is down -50.18%. VBIV lost -$0.27 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for VBI Vaccines Inc click here.

More About VBI Vaccines Inc

VBI Vaccines Inc is a US-based commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology. Click Here to get the full Stock Report for VBI Vaccines Inc stock.